IKT Inhibikase Therapeutics Company Short-Term Debts
This chart of the market price for Inhibikase Therapeutics (IKT) reflects the asset's dynamics, with a metric of 0.00. The business relies on developing advanced targeted therapies for individuals with severe brain injuries, anticipating reimbursement from funds and insurers. High testing costs and strict FDA oversight create barriers to entry, while patent protection provides speculative potential until the final stages of verification.
Metric breakdowns and analytics for Inhibikase Pharma (IKT)
- current quotes and average value forecast:
- market capitalization data:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Inhibikase Therapeutics|IKT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Inhibikase Therapeutics|IKT - Company Debts|Debts to Book Capitalization Inhibikase Therapeutics, Inc.|IKT - Long-Term Debt Volume|Company Short-Term Debt Inhibikase Therapeutics|Quick Ratio inhibikase.com
- earnings and multiples data:
Fundamental company valuation:Inhibikase Therapeutics, Inc. (IKT)
Fundamental liquidity analysis allows for an assessment of the issuer's financial stability. This indicator aggregates all obligations due for repayment within twelve months. By analyzing current debt on loans and borrowings, an investor determines the balance between debt load and investment potential. For Inhibikase Therapeutics (IKT), this parameter is critical when financing clinical trials for Parkinson's disease. Controlling short-term payments confirms the company's ability to sustain innovative developments.
Competitors of Inhibikase Therapeutics
BIIB - Company Short-Term Debt|Short-Term Debt Neurocrine|RGC: Company Short-Term Debts|AXSM - Short-Term Debt Volume|Company Short-Term Debt ACADIA Pharmaceuticals|Company Short-Term Indebtedness XENE (xenon-pharma.com)|Company Short-Term Debts VKTX|SUPN (Supernus Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|Short-Term Debt Volume Denali Corp (DNLI)|Harmony Biosciences - Company Short-Term Debts|BHVN: Company Short-Term Debt|AMLX: Company Short-Term Debts|TRVI - Short-Term Debt Volume|Company Short-Term Debt Praxis Medicines|Company Short-Term Debts Anavex Life Sciences Corp|Company Short-Term Debts CBLL|Company Short-Term Debts Prothena Corporation plc (PRTA)|Company Short-Term Debt Alector ALEC|Short-Term Debt Volume Annexon Biosciences (ANNX)|Omeros Corp. - Company Short-Term Debts|Short-Term Debt Neurogene Therapeutics|ACIU (AC Immune) - Company Current Liabilities|voyagertherapeutics.com - Company Short-Term Loans and Borrowings|Company Current Liabilities NMRA|SCLX (Scilex Holding) - Amount of Current Liabilities|Company Short-Term Debts TVGN|ACOG (alphacognition.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|cassavasciences.com (SAVA) - Short-Term Debt|ASRT - Company Short-Term Debt|Company Short-Term Loans and Borrowings COYA (Coya Therapeutics, Inc.)|VTGN: Company Short-Term Debts|Ovid Therapeutics (OVID) - Company Short-Term Debts|Company Short-Term Debt Acumen Pharmaceuticals|cervomed.com - Current Liabilities|Company Short-Term Debts ATHE|CLNN - Short-Term Debt|PepGen - Company Current Liabilities|Company Short-Term Debts jupiterneurosciences.com JUNS|RLMD: Company Current Liabilities|annovisbio.com - Amount of Current Liabilities|GRCE: Company Short-Term Debts|AIFF - Short-Term Debt Volume|KLTO (ANEW Medical) - Company Short-Term Debts|Company Current Liabilities NeuroSense Therapeutics, Ltd. (NRSN)|Company Short-Term Debt Reviva Pharmaceuticals (RVPH)|Short-Term Debt Volume metaviatx.com|Company Short-Term Debts NRXS (NeurAxis)|Short-Term Debt Volume Helius Medical Technologies, Inc. (HSDT)|PASG - Company Short-Term Debt|NEUP - Company Short-Term Debts|NERV (Minerva Neurosciences) - Company Current Liabilities|ATHA: Amount of Current Liabilities|Company Short-Term Debt Addex Therapeutics Ltd|Company Short-Term Indebtedness ALZN (Alzamend)|Company Short-Term Debts CYCN|PTIX - Short-Term Debt|Pasithea Therapeutics Corp. - Company Current Liabilities|Company Short-Term Debts Cortigent Inc CRGT|ATXI - Company Short-Term Debt|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Short-Term Debt Chromocell (CHRO)|ELYM (Eliem Therapeutics, Inc.) - Company Short-Term Debts|Intra-Cellular (ITCI) - Short-Term Debt Volume|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Marinus Pharmaceuticals Inc - Company Short-Term Indebtedness|Company Short-Term Debts NKGN (NKGen)|Company Short-Term Loans and Borrowings NRBO|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume synaptogen.com SNPX|TRVN: Company Short-Term Debts|VIGL (Vigil Neuroscience, Inc.) - Company Short-Term Debt|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Cerevel Corp (CERE) - Short-Term Debt Volume